IO Biotech Inc. (IOBT)
NASDAQ: IOBT
· Real-Time Price · USD
2.10
-0.06 (-2.78%)
At close: Aug 18, 2025, 3:59 PM
2.13
1.43%
Pre-market: Aug 19, 2025, 06:51 AM EDT
IO Biotech Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -98.45M | -95.49M | -90.34M | -88M | -88.5M | -86.08M | -79.97M | -73.98M | -71.3M | -71.46M | -72.7M | -58.1M | -81.33M | -67.88M | -49.12M | -51.52M | -9.79M |
Depreciation & Amortization | 865K | 849K | 831K | 820K | 793K | 756K | 745K | 670K | 494K | 540K | 350K | 230K | 220K | 2.00 | n/a | 1K | n/a |
Stock-Based Compensation | 6.53M | 4.96M | 3.33M | 1.65M | 7.74K | 8.06K | 8.16K | 2.41M | 3.76M | 5.38M | 6.68M | 4.76M | 3.41M | 1.79M | 508K | 41K | 36.02K |
Other Working Capital | 7.9M | 221K | -763K | -3.49M | -1.98M | 5.44M | 4.93M | 4.95M | 5.42M | 2.01M | -2.97M | -8.32M | -7.15M | -4.18M | -3.62M | 2.37M | -169.95K |
Other Non-Cash Items | 4.3M | 6.79M | 6.45M | 29.76M | 49.67M | 46.92M | 42.08M | 20.4M | -497.29K | -219.28K | -2.29K | -2.63M | 26.38M | 26.22M | 26.53M | 29.14M | -148.42K |
Deferred Income Tax | n/a | n/a | -4.73M | -26.06M | -47.25M | -47.25M | -42.44M | -21.1M | 87K | 87K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 8.72M | 1M | -2.15M | -2.94M | -2.4M | 5.86M | 9.96M | 7.53M | 10.24M | 4.19M | -862K | -5.47M | -6.26M | -776K | -2.41M | 3.79M | 755.05K |
Operating Cash Flow | -80.49M | -82.35M | -85.52M | -80.7M | -81.98M | -71.74M | -61.47M | -58.83M | -53.58M | -59.73M | -66.44M | -61.21M | -57.6M | -40.65M | -24.5M | -18.55M | -9.15M |
Capital Expenditures | -61K | -44K | -145K | -159K | -186K | -323K | -560K | -654K | -722K | -690K | -494K | -376K | -269K | -153K | -3 | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -61K | -44K | -145K | -159K | -186K | -323K | -560K | -654K | -722K | -690K | -494K | -379K | -272K | -156K | -3K | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -10K | 71.86M | 71.86M | 71.86M | 71.87M | n/a | n/a | n/a | 103.35M | 103.35M | 103.35M | 103.01M | -340K | -350K | -350K |
Financial Cash Flow | n/a | n/a | -10K | 71.86M | 69.11M | 69.11M | 69.12M | -2.75M | n/a | n/a | 187.54M | 187.54M | 187.54M | 252.95M | 65.41M | 70.51M | 70.51M |
Net Cash Flow | -80.9M | -83.16M | -85.32M | -9.35M | -10.54M | 603K | 14.33M | -60.03M | -59.38M | -68.94M | 105.96M | 115.64M | 124.95M | 208.39M | 39.16M | 51.64M | 60.11M |
Free Cash Flow | -80.55M | -82.39M | -85.66M | -80.86M | -82.17M | -72.06M | -62.03M | -59.48M | -54.3M | -60.42M | -66.94M | -61.58M | -57.87M | -40.8M | -24.5M | -18.55M | -9.15M |